Perplexing results from Duchenne trial raise more questions

Scientifically, Pfizer's gene therapy did what it was supposed to do. Yet the participants didn't benefit at all

October 21, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies  Clinical trial results show boys did not improve even though a biomarker target was achieved, which suggests an FDA standard is inadequate. By Jason Mast and Adam Feuerstein STAT+ | Pharma execs donated more to Democrats in campaign's final stretch A STAT review of contributions by CEOs and others showed most executives just gave to their companies' political action committees. By Rachel Cohrs Zhang Philadelphia-area health systems end use of four race-based algorithms to guide care The hospitals' decision marks one of the largest and broadest efforts to date to remove race from widely used clinical algorithms By Usha Lee McFarling and Katie Palmer Joe Raedle/Getty Images STAT+ | Behind CVS CEO's ouster, a question: Do a pharmacy and a health insurer make sense together? CVS Health is running out of time to answer an existential question about its strategy, as investors clamor for a turnaround. By Matthew Herper A telling chart shows how health insurers found a way to boost profits by limiting care for seniors This week in health care news: Senators investigate care denials in Medicare Advantage and the CEO of CVS Health is ousted. By Bob Herman After shingles damaged her vision, this former eye surgeon looked for a way to keep it from happening to others NYU researcher Elisabeth Cohen reports study results 14 years in the making: Low-dose antiviral cut risk of vision loss from shingles By Megan Molteni Rocco Fazzari for The Examination STAT+ | Former FDA lawyers join tobacco industry in 'epic' fight against the agency Former agency insiders are helping vaping companies and tobacco firms press their case. By Kathryn Kranhold

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser